District Of Columbia 2023-2024 Regular Session

District Of Columbia Council Bill PR25-0826

Introduced
5/22/24  
Refer
6/11/24  
Introduced
5/22/24  
Report Pass
7/16/24  
Refer
6/11/24  
Report Pass
7/16/24  

Caption

Board of Pharmacy Rodrick McGill Confirmation Resolution of 2024

Impact

The impact of this resolution on state laws primarily involves reinforcing the structure and functioning of the Board of Pharmacy, a key regulatory body that oversees pharmacy operations in the District. By confirming Mr. McGill, the Council aims to enhance the Board's effectiveness in addressing consumer issues related to pharmacy services. This confirmation aids in maintaining a balance between professional practice and consumer advocacy, which is essential for effective regulation in the healthcare sector.

Summary

PR25-0826, known as the Board of Pharmacy Rodrick McGill Confirmation Resolution of 2024, addresses the appointment of Mr. Rodrick McGill as a consumer member of the Board of Pharmacy. This resolution is crucial as it pertains to ensuring that consumer representation is included on the Board, which plays a vital role in overseeing pharmacy practices and supporting public health initiatives within the District of Columbia. The resolution confirms Mr. McGill's term, which is set to end on March 12, 2027, thereby securing continuity in the Board's operations and decision-making processes.

Sentiment

The sentiment surrounding PR25-0826 appears to be largely supportive among the members of the Council, reflecting a consensus on the importance of having consumer representation on the Board of Pharmacy. This confirmation is viewed as a step toward greater inclusivity and oversight in pharmacy practices, which benefits public health outcomes. The supportive tone indicates that there is strong recognition of the significance of consumer voices in regulatory matters, especially in healthcare.

Contention

While the resolution was recognized for its supportive attributes, the underlying contentions occasionally arise surrounding membership on such regulatory boards. Potential discussions may focus on the diversity of perspectives represented within the Board of Pharmacy, and whether appointments adequately reflect the varied interests of consumers. However, PR25-0826 itself does not denote any significant opposition, emphasizing a smooth confirmation process intended to solidify Mr. McGill's role going forward.

Companion Bills

No companion bills found.

Previously Filed As

DC PR25-0725

Board of Pharmacy Benjamin Miles Confirmation Resolution of 2024

DC PR25-0999

Board of Pharmacy Dr. Jamila Jorden Confirmation Resolution of 2024

DC PR25-0760

Board of Medicine Amr Madkour Confirmation Resolution of 2024

DC PR25-1036

Clemency Board Phylisa Carter Confirmation Resolution of 2024

DC PR25-0792

Board of Dentistry Dr. Imani Lewis Confirmation Resolution of 2024

DC PR25-0633

Board of Veterinary Medicine Blair Zervos Confirmation Resolution of 2024

DC PR25-0791

Board of Dentistry Dr. Chanelle Roberts Confirmation Resolution of 2024

DC PR25-0505

Board of Dentistry John Bailey Confirmation Resolution of 2023

DC PR25-0475

Alcoholic Beverage and Cannabis Board Silas H. Grant, Jr. Confirmation Resolution of 2023

DC PR25-1010

Board of Barber and Cosmetology Ajia Minnis Confirmation Resolution of 2024

Similar Bills

No similar bills found.